Latest Trustees of Columbia University in the City of New Stock Portfolio
Trustees of Columbia University in the City of New Performance:
2025 Q3: 7.88%YTD: 13.95%2024: 1.38%
Performance for 2025 Q3 is 7.88%, and YTD is 13.95%, and 2024 is 1.38%.
About Trustees of Columbia University in the City of New and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Trustees of Columbia University in the City of New York reported an equity portfolio of $655.3 Millions as of 30 Sep, 2025.
The top stock holdings of Trustees of Columbia University in the City of New York are SPY, SRZN, TNYA. The fund has invested 99.7% of it's portfolio in SPDR S&P 500 ETF TR and 0.1% of portfolio in SURROZEN INC.
The fund managers got completely rid off VIGIL NEUROSCIENCE INC (VIGL), HEICO CORP NEW (HEI) and VOR BIOPHARMA INC (VOR) stocks. They significantly reduced their stock positions in SPDR S&P 500 ETF TR (SPY). Trustees of Columbia University in the City of New York opened new stock positions in RAPT THERAPEUTICS INC (RAPT) and VOR BIOPHARMA INC (VOR).
The top stock holdings of Trustees of Columbia University in the City of New York are SPY, SRZN, TNYA. The fund has invested 99.7% of it's portfolio in SPDR S&P 500 ETF TR and 0.1% of portfolio in SURROZEN INC.
The fund managers got completely rid off VIGIL NEUROSCIENCE INC (VIGL), HEICO CORP NEW (HEI) and VOR BIOPHARMA INC (VOR) stocks. They significantly reduced their stock positions in SPDR S&P 500 ETF TR (SPY). Trustees of Columbia University in the City of New York opened new stock positions in RAPT THERAPEUTICS INC (RAPT) and VOR BIOPHARMA INC (VOR).
Trustees of Columbia University in the City of New Annual Return Estimates Vs S&P 500
Our best estimate is that Trustees of Columbia University in the City of New York made a return of 7.88% in the last quarter. In trailing 12 months, it's portfolio return was 13.95%.
New Buys
| Ticker | $ Bought |
|---|---|
| rapt therapeutics inc | 236,546 |
| vor biopharma inc | 223,868 |
New stocks bought by Trustees of Columbia University in the City of New
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| spdr s&p 500 etf tr | -11.87 |
Trustees of Columbia University in the City of New reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| vigil neuroscience inc | -1,534,140 |
| vor biopharma inc | -148,894 |
| heico corp new | -824,636 |
Trustees of Columbia University in the City of New got rid off the above stocks
Sector Distribution
Trustees of Columbia University in the City of New York has about 99.7% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 99.7 |
Market Cap. Distribution
Trustees of Columbia University in the City of New York has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 99.7 |
Stocks belong to which Index?
About 0% of the stocks held by Trustees of Columbia University in the City of New York either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 99.9 |
Trustees of Columbia University in the City of New Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Trustees of Columbia University in the City of New
Trustees of Columbia University in the City of New York has 8 stocks in it's portfolio. SRZN proved to be the most loss making stock for the portfolio. SPY was the most profitable stock for Trustees of Columbia University in the City of New York last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| HEI | heico corp new | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RAPT | rapt therapeutics inc | 0.04 | 9,172 | 236,546 | new | |||
| SPY | spdr s&p 500 etf tr | 99.69 | 980,596 | 653,253,000 | reduced | -11.87 | ||
| SRZN | surrozen inc | 0.09 | 47,930 | 617,579 | unchanged | 0.00 | ||
| SRZN | surrozen inc | 0.00 | 33,333 | 517 | unchanged | 0.00 | ||
| TNYA | tenaya therapeutics inc | 0.07 | 291,828 | 472,761 | unchanged | 0.00 | ||
| VIGL | vigil neuroscience inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| VOR | vor biopharma inc | 0.03 | 4,595 | 223,868 | new | |||
| VOR | vor biopharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| XLO | xilio therapeutics inc | 0.03 | 249,635 | 210,442 | unchanged | 0.00 | ||
| q32 bio inc | 0.04 | 133,903 | 265,128 | unchanged | 0.00 | |||